Authors: Chopra V, Flanders SA, O'Malley M PMID: 33175566 PMCID: PMC7707210 DOI: 10.7326/M20-5661 Abstract Background: Although characteristics and in-hospital outcomes for persons with coronavirus disease 2019 (COVID-19) have been well described, less is known about the longer-term outcomes of hospitalized patients. Objective: To describe 60-day postdischarge clinical, financial, and mental health outcomes of patients with [...]

Authors: Patterson BK, seethamraju H, Dhody K, Corley MJ, Kazempour K, Lalezari J et al. PMID: 33186704 PMCID: PMC7654230 DOI: 10.1016/j.ijid.2020.10.101 Abstract Objective: Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is now a global pandemic. Emerging results indicate a dysregulated immune response. Given the role of CCR5 in immune cell migration and inflammation, [...]

Authors: Bagate F, Tuffet S, Masi P, Perier F, Razazi K PMID: 33150525 PMCID: PMC7641257 DOI: 10.1186/s13613-020-00769-2 Abstract Background: In COVID-19 patients with severe acute respiratory distress syndrome (ARDS), the relatively preserved respiratory system compliance despite severe hypoxemia, with specific pulmonary vascular dysfunction, suggests a possible hemodynamic mechanism for VA/Q mismatch, as hypoxic vasoconstriction alteration. [...]

Authors: Zuo Y, Estes SK, Ali RA, Gandhi AA, Shi H PMID: 33139519 PMCID: PMC7724273 DOI: 10.1126/scitranslmed.abd3876 Abstract Patients with COVID-19 are at high risk for thrombotic arterial and venous occlusions. Lung histopathology often reveals fibrin-based blockages in the small blood vessels of patients who succumb to the disease. Antiphospholipid syndrome is an acquired and [...]

Authors: Shi Z, Puyo CA PMID: 33177829 PMCID: PMC7649937 DOI: 10.2147/TCRM.S273700 Abstract The novel coronavirus disease (COVID-19) is caused by a virus (SARS-Cov-2) and is known for inducing multisystem organ dysfunction associated with significant morbidity and mortality. Current therapeutic strategies for COVID-19 have failed to effectively reduce mortality rate, especially for elderly patients. A newly [...]

Authors: Balagholi S, Dabbaghi R, Eshghi P, Mousavi SA, Heshmati F, Mohammadi S PMID: 33162341 PMCID: PMC7605792 DOI: 10.1016/j.transci.2020.102993 Abstract Therapeutic plasmapheresis (TP) is the process of the separation and removal of plasma from other blood components and is considered as an adjunctive treatment strategy to the discarded abnormal agent in the management of respiratory [...]

More than 1.6 million Americans have been infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and more than 10 times that number carry antibodies to it.

Authors: Payen D DOI:10.1097/CCM.0000000000004765 Abstract OBJECTIVES: Respiratory failure, multiple organ failure, shortness of breath, recovery, and mortality have been identified as critically important core outcomes by more than 9300 patients, health professionals, and the public from 111 countries in the global coronavirus disease 2019 core outcome set initiative. The aim of this project was to [...]

Authors: Bernheim A, Mei X, Huang M, Yang Y, Fayad ZA, Zhang N et al. PMID: 33142125 PMCID: PMC7585632 DOI: 10.1016/j.clinimag.2020.10.035 Abstract Objectives: We performed a systematic review and meta-analysis of the prevalence of chest CT findings in patients with confirmed COVID-19 infection. Methods: Systematic review of the literature was performed using PubMed, Scopus, Embase, [...]

Authors: Agarwal A, Mukherjee A, Kumar G, Chatterjee P, Bhatnager T PMID: 33093056 PMCID: PMC7578662 DOI: 10.1136/bmj.m3939 Abstract Objective: To investigate the effectiveness of using convalescent plasma to treat moderate coronavirus disease 2019 (covid-19) in adults in India. Design: Open label, parallel arm, phase II, multicentre, randomised controlled trial. Setting: 39 [...]